PUBLISHER: The Business Research Company | PRODUCT CODE: 2127372
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127372
A magnetic resonance imaging (MRI)-compatible syringe pump is a specially engineered infusion device designed to safely administer precise volumes of fluids, medications, or contrast agents throughout magnetic resonance imaging procedures. It is constructed using non-magnetic materials to avoid interference with the magnetic resonance imaging system and preserve optimal image quality. Magnetic resonance imaging (MRI)-compatible syringe pumps support continuous or programmable infusion, ensuring safe patient management and dependable treatment during the imaging process.
The primary product categories of magnetic resonance imaging (MRI)-compatible syringe pumps include single-channel magnetic resonance imaging-compatible syringe pumps, dual-channel magnetic resonance imaging-compatible syringe pumps, and multi-channel magnetic resonance imaging-compatible syringe pumps. Single-channel magnetic resonance imaging-compatible syringe pumps are infusion devices engineered to accurately administer medications, contrast agents, or other fluids during MRI procedures while maintaining safe compatibility with magnetic environments. These pumps are available as battery-powered magnetic resonance imaging-compatible syringe pumps, alternating current-powered magnetic resonance imaging-compatible syringe pumps, and hybrid-powered magnetic resonance imaging-compatible syringe pumps, and are intended for adult, pediatric, and neonatal patients. Their applications include contrast agent delivery, drug delivery, anesthesia support, critical care infusion, and research activities, and they are utilized by hospitals, diagnostic imaging centers, ambulatory surgical centers, research institutes, and specialty clinics.
Tariffs are influencing the magnetic resonance imaging (MRI)-compatible syringe pump market by increasing the cost of imported non-magnetic components, electronic control systems, precision infusion mechanisms, and specialized medical device materials. The effects are greater across single-channel, dual-channel, and multi-channel MRI-compatible syringe pumps, as well as battery-powered and hybrid-powered systems, because of their dependence on global supply chains, particularly in North America, Europe, and Asia-Pacific. Rising equipment costs may influence procurement decisions made by hospitals, diagnostic imaging centers, and specialty clinics while also encouraging local manufacturing, supplier diversification, and regional production of MRI-compatible infusion technologies.
The magnetic resonance imaging (mri)-compatible syringe pump market research report is one of a series of new reports from The Business Research Company that provides magnetic resonance imaging (mri)-compatible syringe pump market statistics, including magnetic resonance imaging (mri)-compatible syringe pump industry global market size, regional shares, competitors with a magnetic resonance imaging (mri)-compatible syringe pump market share, detailed magnetic resonance imaging (mri)-compatible syringe pump market segments, market trends and opportunities, and any further data you may need to thrive in the magnetic resonance imaging (mri)-compatible syringe pump industry. This magnetic resonance imaging (mri)-compatible syringe pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The magnetic resonance imaging (MRI)-compatible syringe pump market size has grown strongly in recent years. It will grow from $0.32 billion in 2025 to $0.34 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing adoption of MRI diagnostic procedures, rising demand for accurate contrast agent administration, growing need for patient safety during imaging procedures, expansion of advanced diagnostic imaging facilities, increasing utilization of infusion systems in critical care applications.
The magnetic resonance imaging (MRI)-compatible syringe pump market size is expected to see strong growth in the next few years. It will grow to $0.46 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing demand for advanced MRI guided procedures, rising adoption of programmable infusion technologies, growing integration of smart monitoring capabilities, expanding healthcare infrastructure investments, increasing focus on precision medication delivery. Major trends in the forecast period include increasing adoption of mri compatible infusion technologies, growing development of programmable syringe pump systems, rising demand for safe contrast agent delivery solutions, expansion of non-magnetic medical device designs, increasing preference for continuous infusion during imaging procedures.
The increasing global prevalence of complex chronic diseases is expected to drive the growth of the magnetic resonance imaging-compatible syringe pump market in the coming years. Complex chronic diseases refer to the presence of one or more long-term health conditions that are severe, progressive, or interconnected and require continuous, coordinated, and multidisciplinary healthcare management. The increasing prevalence of complex chronic diseases worldwide is fueled by the aging population, as older individuals have a higher risk of developing multiple chronic health conditions that require ongoing and integrated medical care. The growing burden of complex chronic diseases increases the requirement for continuous medication infusion during magnetic resonance imaging (MRI) procedures, thereby boosting the demand for magnetic resonance imaging-compatible syringe pumps that enable safe and accurate drug delivery while supporting effective diagnosis and uninterrupted treatment for patients with multiple chronic conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal agency, 76.4% (194 million) of US adults had at least one chronic condition in 2023, while 51.4% (130 million) were affected by multiple chronic conditions. Therefore, the increasing global prevalence of complex chronic diseases is contributing to the expansion of the magnetic resonance imaging-compatible syringe pump market.
The growing number of magnetic resonance imaging procedures is expected to drive the growth of the magnetic resonance imaging-compatible syringe pump market in the forecast period. Magnetic resonance imaging procedures refer to non-invasive diagnostic imaging tests that utilize strong magnetic fields and radio waves to generate detailed images of internal organs, tissues, and anatomical structures. The increasing number of magnetic resonance imaging procedures is supported by the rising demand for accurate and non-invasive diagnostic imaging solutions, as MRI enables detailed visualization of soft tissues and organs without the use of ionizing radiation. The rising adoption of magnetic resonance imaging (MRI) procedures is increasing the demand for magnetic resonance imaging-compatible syringe pumps to facilitate the safe and continuous administration of contrast agents and medications during imaging procedures. For instance, in December 2025, according to the National Institutes of Health, a US-based government agency, CT imaging activity increased by 60% and MRI activity increased by 31%, indicating continued growth in diagnostic imaging procedures over time. Therefore, the growing number of magnetic resonance imaging procedures is driving the growth of the magnetic resonance imaging-compatible syringe pump market.
Key companies operating in the magnetic resonance imaging (MRI)-compatible syringe pump market are concentrating on developing MRI-compatible infusion solutions, including integrated syringe pump stations, to enhance medication safety, ensure uninterrupted drug delivery, and improve workflow efficiency during magnetic resonance imaging procedures. These systems provide MRI-safe operation, continuous infusion capabilities, remote monitoring, and compatibility with high-strength magnetic field environments, enabling clinicians to administer essential medications without interrupting diagnostic imaging or compromising patient safety. For example, in August 2023, Mindray, a China-based medical device company, launched the BeneFusion MRI Station, an MRI-compatible infusion solution designed to support safe and continuous medication delivery throughout MRI examinations. The system integrates MRI-compatible syringe and infusion pumps with centralized monitoring capabilities, allowing healthcare professionals to maintain accurate infusion therapy while minimizing workflow disruptions in MRI suites. It provides a dedicated MRI-compatible infusion platform. Mindray enables hospitals to improve medication safety, enhance clinical efficiency, and support uninterrupted patient care during MRI procedures.
Major companies operating in the magnetic resonance imaging (mri)-compatible syringe pump market report are B. Braun Melsungen AG, Fresenius Kabi AG, Becton Dickinson and Company, Bracco Imaging S.p.A., Guerbet SA, ulrich medical USA Inc., IRadimed Corporation, ICU Medical Inc., Nemoto Kyorindo Co. Ltd., Shenzhen Antmed Co. Ltd., Chemyx Inc., Harvard Apparatus, MEDTRON AG, Apollo RT Co. Ltd.
North America was the dominant region in the magnetic resonance imaging (MRI)-compatible syringe pump market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the magnetic resonance imaging (MRI)-compatible syringe pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the magnetic resonance imaging (MRI)-compatible syringe pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The magnetic resonance imaging-compatible syringe pump market consists of sales of magnetic resonance imaging-compatible pole mount, power adapter, and rechargeable battery pack. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Magnetic Resonance Imaging (MRI)-Compatible Syringe Pump Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses magnetic resonance imaging (mri)-compatible syringe pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for magnetic resonance imaging (mri)-compatible syringe pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The magnetic resonance imaging (mri)-compatible syringe pump market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.